Yasmine Ayoub (yasmine.ayoub@va.gov

Article

Pembrolizumab Dose Conversion Adoption and Immune-Mediated Adverse Events

Author:: Yasmine Ayoub (yasmine.ayoub@va.gov

Publish date: October 1, 2021

Read More